Table of Content

1. Introduction

2. Research & Methodology


3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.1.1 High Quality Vaccines
4.1.2 Growing Number of Aging Population
4.1.3 Increasing Awareness
4.1.4 Increasing Government Expenditure
4.1.5 Affordability of Vaccines

4.2 Challenges

4.2.1 Research and Development Capabilities
4.2.2 Stringent Quality Management System
4.2.3 Long Development Time Frame
4.2.4 Intensive Capital Requirement

4.3 Opportunities

4.3.1 Implementation of Two Child Policy
4.3.2 Improving Vaccine Provision and Access


5. China Vaccine Market

5.1 Public
5.2 Private


6. China Vaccine Doses

6.1 Public
6.2 Private


7. Market Share – China Vaccine Analysis

7.1 By Sectors
7.2 By Vaccine Doses Share
7.3 By Products Type
7.4 By Disease Type


8. Meningococcal Meningitis Vaccine

8.1 Market

8.1.1 Total China
8.1.2 Public
8.1.3 Private

8.2 Vaccine Doses

8.2.1 Total China
8.2.2 Public
8.2.3 Private

8.3 Vaccine Pipeline


9. Pneumococcal Vaccines

9.1 Market
9.2 Doses
9.3 Vaccine Pipeline


10. DTP Vaccine

10.1 Market – DTP Vaccine

10.1.1 DTaP Vaccine
10.1.2 DTcP and Combination Vaccine

10.2 Doses – DTP Vaccine

10.2.1 Public
10.2.2 Private

10.3 Vaccine Pipeline


11. Rabies Vaccine Market


12. Ebola Vaccine

12.1 Market
12.2 Vaccine Pipeline


13. Products Type - China Vaccine Market

13.1 MCV4
13.2 MPSV4
13.3 MCV2-Hib
13.4 MCV2
13.5 MPSV2 and Men A
13.6 PCV13
13.7 PPV23


14. Vaccine Regulatory Authority of China


15. Required and Recommended Vaccinations for China Travel


16. Mergers and Acquisitions


17. Company Analysis

17.1 Sinopharm Group (China National Biotec Group Company Limited)

17.1.1 Overview
17.1.2 Recent Development
17.1.3 Vaccine Pipeline
17.1.4 Revenue Analysis

17.2 Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd

17.2.1 Overview
17.2.2 Recent Development
17.2.3 Vaccine Pipeline
17.2.4 Revenue Analysis

17.3 Chongqing Zhifei Biological Products Co Ltd

17.3.1 Overview
17.3.2 Recent Development
17.3.3 Vaccine Pipeline
17.3.4 Revenue Analysis

17.4 Hualan Biological Engineering Inc.

17.4.1 Overview
17.4.2 Recent Development
17.4.3 Revenue Analysis

17.5 Liaoning Chengda Co. Ltd.

17.5.1 Overview
17.5.2 Recent Development
17.5.3 Revenue Analysis

17.6 Walvax Biotechnology Co. Ltd.

17.6.1 Overview
17.6.2 Recent Development
17.6.3 Vaccine Pipeline
17.6.4 Revenue Analysis



List of Figures



Figure-01: China Vaccine Market in (Million US$), 2018 & 2025
Figure-02: China – Private Vaccine Market Growing Segment in (Million US$), 2018 – 2025
Figure-03: China – Vaccine Market in (Million US$) 2014 – 2018
Figure-04: China – Forecast for Vaccine Market in (Million US$) 2019 – 2025
Figure-05: China – Public Vaccine Market (Million US$) 2014 – 2018
Figure-06: China – Forecast for Public Vaccine Market in (Million US$) 2019 – 2025.
Figure-07: China – Private Vaccine Market in (Million US$) 2014 – 2018
Figure-08: China – Forecast for Private Vaccine Market in (Million US$) 2019 – 2025
Figure-09: China Vaccine Doses in (Million), 2014 – 2018
Figure-10: China – Forecast for Vaccine Doses in (Million), 2019 – 2025
Figure-11: China Public Vaccine Doses in (Million ), 2014 – 2018
Figure-12: China – Forecast for Public Vaccine Doses in (Million), 2019 – 2025
Figure-13: China Private Vaccine Doses in (Million ), 2014 – 2018
Figure-14: China – Forecast for Private Vaccine Doses in (Million), 2019 – 2025
Figure-15: China – Vaccine Market Share by Sectors in (Percent), 2014 – 2018
Figure-16: China – Forecast Vaccine Market Share by Sectors in (Percent), 2019 – 2025
Figure-17: China – Vaccine Market Share by Doses in (Percent), 2014 – 2018 Figure-18: China – Forecast for Vaccine Market Share by Doses in (Percent), 2019 – 2025
Figure-19: China – Meningococcal Meningitis Vaccine Market (Million US$), 2014 – 2018
Figure-20: China – Forecast For Meningococcal Meningitis Vaccine Market (Million US$), 2019- 2025
Figure-21: Public - Meningococcal Meningitis Vaccine Market (Million US$), 2014 – 2018
Figure-22: Public - Forecast for Meningococcal Meningitis Vaccine Market (Million US$), 2019 – 2025
Figure-23: Private – Meningococcal Meningitis Vaccine Market (Million US$), 2014 – 2018
Figure-24: Private – Forecast for Meningococcal Meningitis Vaccine Market (Million US$), 2019 - 2025
Figure-25: China – Meningococcal Meningitis Doses (Million), 2014 – 2018
Figure-26: China – Forecast for Meningococcal Meningitis Doses (Million), 2019 – 2025
Figure-27: Public - Meningococcal Meningitis Doses (Million), 2014 – 2018
Figure-28: Public - Forecast for Meningococcal Meningitis Doses (Millions), 2019 – 2025
Figure-29: Private – Meningococcal Meningitis Doses (Million), 2014 – 2018
Figure-30: Private – Forecast for Meningococcal Meningitis Doses (Millions), 2019 – 2025
Figure-31: China – Pneumococcal Vaccines Market (Million US$), 2014 – 2018
Figure-32: China – Forecast For Pneumococcal Vaccines Market (Million US$), 2019 – 2025
Figure-33: China – Pneumococcal Vaccines Doses (Million), 2014 – 2018
Figure-34: China – Forecast For Pneumococcal Vaccines Doses in Million, 2019 – 2025
Figure-35: China – DTP Vaccine Market (US$ Million), 2014 – 2018
Figure-36: China – Forecast For DTP Vaccine Market in (US$ Million), 2019 – 2025
Figure-37: China – DTaP Vaccines Market in (US$ Million), 2014 – 2018
Figure-38: China – Forecast For DTaP Vaccines in (Million US$) ,2019 – 2025
Figure-39: China – DTcP Vaccine Market in (US$ Million), 2014 – 2018
Figure-40: China – Forecast for DTcP Vaccine Market in (Million US$), 2019 – 2025
Figure-41: China – DTP Vaccine Doses in (Million), 2014 – 2018
Figure-42: China – Forecast For DTP Vaccine Doses in (Million), 2019 – 2025
Figure-43: China – DTP Public Vaccine Doses (in Million), 2014 – 2018
Figure-44: China – Forecast for DTP Public Vaccine Doses (in Million), 2019 – 2025
Figure-45: China – DTP Private Vaccine Doses in (Million), 2014 – 2018
Figure-46: China – Forecast for DTP Private Vaccine Doses in (Million), 2019 – 2025
Figure-47: China – Rabies Vaccine Market in (Million US$), 2014 – 2018
Figure-48: China – Forecast For Rabies Vaccine Market in (Million US$) , 2019 – 2025
Figure-49: China – Ebola Vaccine Market in (Million US$), 2018 – 2025
Figure-50: China – Forecast for MCV4 Vaccine Market in (Million US$), 2020 – 2025
Figure-51: China – MPSV4 Vaccine Market in (Million US$), 2017 – 2018
Figure-52: China – Forecast For MPSV4 Vaccine Market in (Million US$), 2019 – 2025
Figure-53: China – MCV2-Hib Vaccine Market in (Million US$), 2017 – 2018
Figure-54: China – Forecast For MCV2-Hib Vaccine Market in (Million US$), 2019 – 2025
Figure-55: China – MCV2 Vaccine Market in (Million US$), 2017 – 2018
Figure-56: China – Forecast For MCV2 Vaccine Market in (Million US$), 2019 – 2025
Figure-58: China – MPSV2 and Men A Vaccine Market in (Million US$), 2017 – 2018
Figure-59: China – Forecast For MPSV2 and Men A Vaccine Market in (Million US$), 2019 – 2025
Figure-60: China – PCV13 Vaccine Market in (Million US$), 2017 – 2018
Figure-61: China – Forecast for PCV13 Vaccine Market in (Million US$), 2019 – 2025
Figure-62: China – PPV23 Vaccine Market in (Million US$), 2017 – 2018
Figure-63: China – Forecast For PPV23 Vaccine Market in (Million US$), 2019 – 2025
Figure-64: Global – Sinopharm Group Revenue in (Million US$) , 2014 – 2018
Figure-65: Global – Forecast For Sinopharm Group Revenue (Million US$), 2019 – 2025
Figure-66: Global –Sinovac Biotech Revenue in (Million US$) 2014 – 2018
Figure-67: Global – Forecast For Sinovac Biotech Revenue in (Million US$), 2019 – 2025
Figure-68: Global –Chongqing Zhifei Revenue in (US$ Million), 2014 – 2018
Figure-69: Global – Forecast For Chongqing Zhifei Revenue in (Million US$), 2019 – 2025
Figure-70: Global – Hualan Biological in Revenue (Million US$), 2014 – 2018
Figure-71: Global – Forecast For Hualan Biological Revenue in (Million US$), 2019 – 2025
Figure-72: Global – Liaoning Chengda Revenue in (Million US$), 2014 – 2018
Figure-73: Global– Forecast For Liaoning Chengda Revenue in (Million US$), 2019 – 2025
Figure-74: Global – Walvax Biotechnology Revenue (Million US$), 2014 – 2018
Figure-75: Global – Forecast For Walvax Biotechnology Revenue in (Million US$), 2019 – 2025

 

List of Tables



Table-01: China – Vaccine Market Share by Products in (Percent), 2017 – 2018
Table-02: China – Forecast for Vaccine Market Share by Products in (Percent), 2019 – 2025
Table-03: China – Vaccine Market Share by Diseases in (Percent), 2014 – 2018
Table-04: China – Forecast for Vaccine Market Share by Diseases in (Percent), 2019 – 2025